Labtec

As the year comes to an end, we extend our warmest wishes for the festive season ahead 🎄🎉. We would like to take this opportunity to thank you for your trust and collaboration throughout the year. Your unwavering support has been vital to our success, and we are deeply grateful to serve you. May the upcoming year bring you abundance, good health, and exciting new opportunities. Thank you for making us a part of your journey. We look forward to continuing our partnership in 2025 and beyond 🎀. Warm regards, The Labtec Team

Join the future of wound healing with the next generation patch. This pharmaceutical project (in development) of a patch for incision and burn wounds to reduce scars was initiated by the Combat Wound Care Group at the US Army Institute of Surgical Research. Key facts : 📌 Drug delivery system ➡️ Matrix Patch, 📌 Aimed indication ➡️ Healing of incision and burn wounds, 📌 Developed and manufactured by Labtec. Get in touch with Dr. Emrah Yıldır, Business Development Manager if you want to join the cutting-edge project. Layered Composite fo Scar Treatment and Prevention. Inventor @Kai leung (if you have his LinkedIn profile). PCT/US2020/044251 US Patent Application 17/588.950 European Patent Application 20847308.2

Labtec has several types of transdermal patches, enabling it to develop a wide range of medical devices. From Drug-in adhesive systems to Matrix systems, we offer four types of transdermal patch, each designed differently to meet the varied needs of our customers. Thanks to their distinctive composition, we offer great flexibility in patch formulation 🧪, enabling their characteristics to be precisely tailored to the specific requirements of your projects. In addition, we offer licensing opportunities for 2 types of transdermal patches 👉 https://lnkd.in/emSedJY2 #TransdermalPatches #MedicalDevices #Pharma #Healthcare #Formulation

As any expert in full service CDMO company, Labtec by AdhexPharma quality system follows the guidelines of the current Good Manufacturing Practices (GMP or cGMP). It complies with the following standards: GMP-ANSM & BfArM, cGMP—Food and Drug Administration (FDA), 21 CFR 210, 211, 820, 21 CFR part 11, ISO 13485. The company achieved FDA approval in 2017, highlighting our commitment to excellence in pharmaceutical manufacturing 🏢. These standards ensure the consistent production of high-quality products while prioritizing safety at every step for the American market. To know more about our technologies and our CDMO services, you can contact our team, link in the comments 👇 #OralFilm #TransdermalPatches #Health #Innovation #Pharma #FDA #US

With 3 production sites, laboratory and formulation, our company is equipped with high-performance industrial equipment for the contract production of patches and oral films. As a CDMO, we handle the entire supply chain, including purchasing, mixing, manufacturing, packaging, and storage. 🧪 Mixing: API and excipients in tanks ranging from 5 to 300 kg ⚙️ Manufacturing: 5 lines, continuously controlled 📦 Packaging: Multiple formats with maximum flexibility, from small to large series 🚪 Storage: 2000 m² capacity in pharmaceutical area The quality system follows the guidelines of the current Good Manufacturing Practices (GMP or cGMP) and complies with cGMP compliant with FDA and EMA standards.

In the world of pharmaceuticals, innovation is the key to unlocking new levels of patient care. Labtec, partnering with AdhexPharma has positioned itself at the forefront of this innovation with its advanced mucoadhesive film technology that is specifically designed to provide immediate, directional, or controlled release of your API. A modern approach to drug delivery that is not just efficient but also patient-friendly. 🔬 The buccal mucosa, located on the inner lining of the cheeks and gums, offers a unique pathway for drug absorption. This route bypasses the gastrointestinal tract and liver metabolism (known as the first-pass effect), enabling faster and more efficient delivery of medication into the bloodstream. Here’s why the buccal mucosa is an ideal target for oral films: - Rich blood supply, - Avoiding digestive enzymes or extreme pH levels, - Rapid onset of action. Let’s connect and discuss how our innovations in oral films can contribute to your project ! #Innovation #Pharma #Healthcare #Patient #OralFilms

We are honored to share that we have been ranked by The Financial Times and STATISTA as the 171st of Europe’s Long-Term Growth Champions! This recognition highlights our sustained sales growth in a time when many are facing economic challenges across the continent. Our team's dedication and resilience have been key to achieving this distinction, and we're excited to continue building on this momentum. Read the full article here 🔗 : https://lnkd.in/dHHF37Qj

🌟 We’re excited to announce that Hugo Vimal, our Head of Business Development, will represent us at the upcoming CNS Summit in Boston, November 10-13! Hugo will present insights on oral film technologies as an innovative approach to CNS disease treatment. This technology is transforming how patients receive care, offering a more accessible and effective way to manage CNS conditions. His talk will cover: - Advantages of oral film as an alternative delivery method, - Improved therapeutic outcomes and ease of administration, - Future directions in CNS treatments through oral film advancements. Timo Taghizadeh will also attend the event to exchange with you. If you're attending CNS Summit, don’t miss this opportunity to learn more about our commitment to enhancing patient care in the CNS space. We’d love to connect with you there! #CNS2024 #CNSSummit2024 #Healthcare #Innovation #Conference #Oralfilm

This October, our team had the opportunity of attending CPhI in Milan, one of the most eagerly awaited events in the pharmaceutical and chemical industries. It was an invaluable opportunity to connect with our incredible clients, exchange ideas, and discuss the exciting road ahead for our partnerships. 🤝 Alongside reconnecting with familiar faces, we were thrilled to make new connections and explore promising business opportunities. The event was a powerful reminder of the innovation and collaboration that drive this industry forward. 🚀 A big thank you to everyone who took the time to meet with us—we’re excited about what the future holds! #CPHI #Pharma #Networking #Innovation #Healthcare #Medicaldevices

AAPS PharmSci 360 in Salt Lake City has officially started ! Stop by our booth #1938 to meet Hugo Vimal. We’d love to connect and discuss how our solutions can support your business in advancing drug development and delivery. Looking forward to seeing you there! 👋 #PharmSci360 #AAPS #BusinessDevelopment #PharmaceuticalScience #Networking #Innovation #Pharma